The biosimilar market is expected to grow between 22% and 30% annually in Europe within the coming years. The main driver of this growth...

The lockdown generated by the pandemic in most of the world has significantly altered the way we engage with customers. Deals that were...

Facing the unexpected At the end of February, coming back from London, where I moderated the second session of Pharma Synergy 2020, I was...